10-K/A Filing

Vicarious Surgical Inc. CIK: 1812173 FY 2020

Filing Information

Form Type	10-K/A
Accession Number	`0001213900-21-028814`
Period End Date	20201231
Filing Date	20210524
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	deh-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 25 Income Statement 7 Cash Flow Statement 26 Stockholders Equity 10

Balance Sheet 25 line items

Line Item	Tag	Value	Unit	Period
Preferred shares, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred shares, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred shares, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Preferred shares, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$1.10M	USD	Point-in-time
Preferred shares, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$132.96K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.23M	USD	Point-in-time
Investments held in Trust Accounts	`AssetsHeldInTrustNoncurrent`	$345.19M	USD	Point-in-time
Total Assets	`Assets`	$346.42M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$13.68K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$112.54K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$126.22K	USD	Point-in-time
Derivative warrant liabilities	`DerivativeLiabilities`	$29.42M	USD	Point-in-time
Deferred underwriting commissions	`DeferredUnderwritingCommissions`	$12.07M	USD	Point-in-time
Total liabilities	`Liabilities`	$41.62M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized, 29,980,468 shares subject to possible redemption at $10.00 per share	`TemporaryEquityCarryingAmountAttributableToParent`	$299.80M	USD	Point-in-time
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$14.46M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-9.46M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	-	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$5.00M	USD	Point-in-time
Total Liabilities and Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$346.42M	USD	Point-in-time

Income Statement 7 line items

Line Item	Tag	Value	Unit	Period
General and administrative expenses	`GeneralAndAdministrativeExpense`	$297.47K	USD	3 Qtrs
General and administrative - related party	`GeneralAndAdministrativeRelatedParty`	$944.84K	USD	3 Qtrs
Loss from Operations	`OperatingExpenses`	$1.24M	USD	3 Qtrs
Change in fair value of derivative warrant liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$7.72M	USD	3 Qtrs
Financing cost - derivative warrant liabilities	`FinancingCostDerivativeWarrantLiabilities`	$690.01K	USD	3 Qtrs
Net gain from investments held in Trust Accounts	`NetGainFromInvestmentsHeldInTrustAccounts`	$191.13K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.46M	USD	3 Qtrs

Cash Flow Statement 26 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-9.46M	USD	3 Qtrs
General and administrative expenses paid by related parties	`RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty`	$16.75K	USD	3 Qtrs
Change in fair value of derivative warrant liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$7.72M	USD	3 Qtrs
Financing cost - derivative warrant liabilities	`FinancingCostDerivativeWarrantLiabilities`	$690.01K	USD	3 Qtrs
Noncash compensation	`NoncashCompensation`	$890.00K	USD	3 Qtrs
Net gain from investments held in Trust Accounts	`IncomeLossFromEquityMethodInvestments`	$191.13K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$132.96K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$13.68K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$27.54K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-427.30K	USD	3 Qtrs
Principal deposited in Trust Accounts	`IncreasedecreaseinprincipalDepositedInTrustAccounts`	$345.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-345.00M	USD	3 Qtrs
Repayment of note payable and advances to related party	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-126.76K	USD	3 Qtrs
Proceeds received from initial public offering, gross	`ProceedsReceivedFromInitialPublicOfferingGross`	$345.00M	USD	3 Qtrs
Proceeds from private placement	`ProceedsFromIssuanceOfPrivatePlacement`	$8.90M	USD	3 Qtrs
Payment of offering costs	`PaymentsOfDebtOfferingCosts`	$7.25M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$346.52M	USD	3 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$1.10M	USD	3 Qtrs
Cash - beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash - beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.10M	USD	Point-in-time
Cash - ending of the period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash - ending of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.10M	USD	Point-in-time
Offering costs paid in exchange for issuance of Class B ordinary shares to Sponsor	`DeferredOfferingCostsPaidInExchangeForIssuanceOfClassbOrdinarySharesToSponsor`	$25.00K	USD	3 Qtrs
Offering costs included in accrued expenses	`DeferredOfferingCostsIncludedInAccruedExpenses`	$85.00K	USD	3 Qtrs
Offering costs included in note payable	`DeferredOfferingCostsIncludedInNotePayable`	$110.02K	USD	3 Qtrs
Deferred underwriting commissions in connection with the initial public offering	`DeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering`	$12.07M	USD	3 Qtrs

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	-	USD	Point-in-time
Balance	`StockholdersEquity`	$5.00M	USD	Point-in-time
Issuance of Class B ordinary shares to Sponsor	`StockIssuedDuringPeriodValueAcquisitions`	$25.00K	USD	3 Qtrs
Sale of units in initial public offering, less fair value of public warrants	`PartnersCapitalAccountPublicSaleOfUnitsNetOfOfferingCosts`	$333.10M	USD	3 Qtrs
Offering costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts`	$-18.85M	USD	3 Qtrs
Excess of cash received over fair value of private placement warrants	`PaymentsForRepurchaseOfPrivatePlacement`	-	USD	3 Qtrs
Shares subject to possible redemption	`SharesSubjectToMandatoryRedemptionNumberOfValue`	$-299.80M	USD	3 Qtrs
New loss	`ProfitLoss`	$-9.46M	USD	3 Qtrs
Balance	`StockholdersEquity`	-	USD	Point-in-time
Balance	`StockholdersEquity`	$5.00M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.